Current and emerging issues with B-type natriuretic peptide. Roundtable discussion.
A brief panel discussion was held on March 23, 2005, in New York City following a live symposium for primary care physicians discussing the roles of B-type natriuretic peptide in a variety of cardiovascular diseases. The participants were Dr. Marc A. Silver, Advocate Christ Medical Center, Oak Lawn, IL; Dr. Clive Rosendorff, Mount Sinai School of Medicine, New York, NY and VA Medical Center, Bronx, NY; Dr. Robert Berkowitz, Hackensack University Medical Center, Hackensack, NJ; and Dr. W. Franklin Peacock IV, The Cleveland Clinic Department of Emergency Medicine, Cleveland, OH. Dr. Silver moderated the discussion. The panel gathered to review some of the questions that emerged from the symposium and the questions raised by the attendees. These are of interest and importance to all interested in heart failure and B-type natriuretic peptide.
Silver
Marc A
MA
Department of Medicine and the Heart Failure Institute, Advocate Christ Medical Center, Oak Lawn, IL 60453, USA. marc.silver@advocatehealth.com
Rosendorff
Clive
C
Berkowitz
Robert
R
Peacock
W Franklin
WF
D006333:Heart Failure / Q000175:diagnosis* / Q000503:physiopathology; D006801:Humans; D020097:Natriuretic Peptide, Brain / Q000032:analysis*; D011379:Prognosis; D018570:Risk Assessment
D020097:Natriuretic Peptide, Brain